Inventor · disambiguated record
Ryu Nagata
Also filed as: NAGATA RYU
15 granted patents·8 pending applications·88 citations·filing 1992–2023
91Inventor score
Files withSUMITOMO PHARMA11DAINIPPON SUMITOMO PHARMA CO5UNIV OSAKA5DANIPPON SUMITOMO PHARMA CO LT1TAKAHASHI YOKO1
Top patents by PatentIndex Score
23 records- 0183US7781479B2Heteroaryl derivativesDAINIPPON SUMITOMO PHARMA CO·Filed 2006·Granted Aug 24, 2010·8 cites·10 claims
- 0279US11548882B2Benzisoxazole compoundUNIV OSAKA·Filed 2019·Granted Jan 10, 2023·2 cites·8 claims
- 0377US7425642B2Heteroaryl derivativeDAINIPPON SUMITOMO PHARMA CO·Filed 2004·Granted Sep 16, 2008·11 cites·9 claims
- 0475US6936736B2Amide derivativeSUMITOMO PHARMA·Filed 2002·Granted Aug 30, 2005·10 cites·3 claims
- 0570US6384033B1Amide derivativeSUMITOMO PHARMA·Filed 2000·Granted May 7, 2002·6 cites·20 claims
- 0668US11976062B2Benzisoxazole compoundUNIV OSAKA·Filed 2022·Granted May 7, 2024·0 cites·14 claims
- 0764US6759429B2Pyrrole derivativesSUMITOMO PHARMA·Filed 2003·Granted Jul 6, 2004·4 cites·9 claims
- 0862US2025170116A1Pharmaceutical composition for preventing and/or treating renal diseaseUNIV OSAKA·Filed 2023·Application pending·0 cites
- 0960US2025073229A1Pharmaceutical composition for preventing and/or treating heart failureUNIV OSAKA·Filed 2022·Application pending·0 cites
- 1059US6495587B1Tricyclic indole-2-carboxylic acid compound used as NMDA receptor antagonistSUMITOMO PHARMA·Filed 2000·Granted Dec 17, 2002·1 cites·7 claims
- 1159US2024307375A1Pharmaceutical composition for preventing and/or treating kidney injury, and autophagy activatorUNIV OSAKA·Filed 2022·Application pending·0 cites
- 1255US5496843ATricyclic indole-2-carboxylic acid derivativesSUMITOMO PHARMA·Filed 1994·Granted Mar 5, 1996·12 cites·19 claims
- 1353US6576656B1Oxindole derivativeSUMITOMO PHARMA·Filed 1999·Granted Jun 10, 2003·15 cites·12 claims
- 1453US6194461B1Nitrone derivativesSUMITOMO PHARMA·Filed 1997·Granted Feb 27, 2001·6 cites·14 claims
- 1551US2008306275A1Novel heteroaryl derivativeDANIPPON SUMITOMO PHARMA CO LT·Filed 2008·Application pending·0 cites
- 1648US5616586ATricyclic quinoxalinedionesSUMITOMO PHARMA·Filed 1992·Granted Apr 1, 1997·9 cites·7 claims
- 1747US5719152ATricyclic quinoxalinedione derivativesSUMITOMO PHARMA·Filed 1996·Granted Feb 17, 1998·4 cites·16 claims
- 1846US7825155B2Oxindole derivative as feeding control agentDAINIPPON SUMITOMO PHARMA CO·Filed 2006·Granted Nov 2, 2010·0 cites·16 claims
- 1943US2004209939A1Pyrrole derivativesSUMITOMO PHARMA·Filed 2004·Application pending·0 cites
- 2040US2010286144A1Heteroaryl derivativesTAKAHASHI YOKO·Filed 2010·Application pending·0 cites
- 2139US2005227978A1Fibrosis inhibitorSUMITOMO PHARMA·Filed 2003·Application pending·0 cites
- 2236US7220773B2Pyrrole derivativeDAINIPPON SUMITOMO PHARMA CO·Filed 2002·Granted May 22, 2007·0 cites·64 claims
- 2334US2011183993A1Cycloalkane derivativeDAINIPPON SUMITOMO PHARMA CO·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ryu Nagata files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →